Related Experiment Videos

Cerebral blood flow velocity changes in preterm infants after a single dose of indomethacin: duration of its effect

F Van Bel1, M Van de Bor, T Stijnen

  • 1Department of Pediatrics, University Hospital, Leiden, The Netherlands.

Pediatrics
|November 1, 1989
PubMed

Insights

Indomethacin reduces cerebral blood flow velocity in preterm infants. This effect lasts for at least 2 hours, potentially impacting vulnerable newborns with patent ductus arteriosus.

Area of Science:

  • Neonatal Medicine
  • Pediatric Neurology
  • Pharmacology

Background:

  • Patent ductus arteriosus (PDA) is common in preterm infants.
  • Indomethacin is used to treat PDA but can affect cerebral circulation.
  • The duration of indomethacin's impact on cerebral blood flow is not well-defined.

Purpose of the Study:

  • To evaluate the duration of indomethacin's effect on cerebral blood flow velocity in preterm infants with PDA.

Main Methods:

  • 24 preterm infants with symptomatic PDA received a single IV dose of indomethacin (0.1 mg/kg).
  • Cerebral blood flow velocity (peak systolic, mean, end-diastolic) in anterior cerebral arteries was measured using Doppler ultrasound before and up to 12 hours post-dose.
  • Serial Doppler investigations tracked changes in flow velocities.

Main Results:

  • Indomethacin caused an immediate decrease in all measured cerebral blood flow velocities.
  • The maximal reduction occurred between 2 and 40 minutes post-administration.
  • Flow velocities began a sustained recovery, with temporal mean flow velocity returning to baseline by 3 hours.

Conclusions:

  • Indomethacin significantly impacts preterm infant cerebral circulation for at least 2 hours.
  • This cerebral circulatory effect may have implications for preterm infants with hemodynamic instability and compromised pulmonary function.

Related Concept Videos